Daily SPAC Update – April 30, 2026

by | Apr 30, 2026

SPAC IPO Update

SPAC IPO Count

Monthly IPOs (last 13 months)
Latest: 16Prior: 11MoM: +5
12
Apr ’25
22
May ’25
10
Jun ’25
13
Jul ’25
8
Aug ’25
14
Sep ’25
14
Oct ’25
10
Nov ’25
22
Dec ’25
24
Jan ’26
27Peak
Feb ’26
11
Mar ’26
16
Apr ’26
Source: Boardroom Alpha
IPO Activity Snapshot6 SPAC IPOs today raising $965M · GCGR ($350M), RREV ($250M), ARBC ($105M), FTHA ($100M), WENC ($100M), + 1 more
Month-to-date: 16 IPOs ($2.65B) vs. prior month 11 ($1.72B) · 12-mo avg: 15.6/mo
SPAC IPO: D. Boral Arc Acquisition Ii Corp. (ARBC)
Ticker: ARBC
Size: $105 Million
Sponsor: Arc Group Acquisition I Corp.D. Boral Arc Acquisition Ii Corp. has launched its $105 million IPO, targeting sectors with high growth potential. The SPAC aims to leverage its experienced sponsor team to identify opportunities in technology and healthcare, areas known for robust expansion and innovation.

SPAC IPO: Forefront Tech Holdings Acquisition Corp (FTHA)
Ticker: FTHA
Size: $100 Million
Sponsor: Forefront Tech Holdings

Forefront Tech Holdings Acquisition Corp has priced its $100 million IPO, focusing on emerging technology sectors. With a strategic emphasis on digital transformation and fintech, this SPAC seeks to capitalize on the accelerating shift towards digital solutions.

SPAC IPO: General Catalyst Global Resilience Merger Corp (GCGR)
Ticker: GCGR
Size: $350 Million
Sponsor: General Catalyst Partners

General Catalyst Global Resilience Merger Corp has launched a substantial $350 million IPO. The SPAC is positioned to identify resilient business models in sectors such as digital health and enterprise software, leveraging the sponsor’s extensive network and industry expertise.

SPAC IPO: Rre Ventures Acquisition Corp. (RREV)
Ticker: RREV
Size: $250 Million
Sponsor: RRE Ventures

Rre Ventures Acquisition Corp. has announced its $250 million IPO, with a focus on technology and consumer sectors. Backed by RRE Ventures, a firm with a strong track record in venture capital, this SPAC aims to identify high-growth targets in rapidly evolving markets.

SPAC IPO: Mountain Crest Acquisition 6 Corp. (MCAH)
Ticker: MCAH
Size: $60 Million
Sponsor: Mountain Crest Capital

Mountain Crest Acquisition 6 Corp. has completed its $60 million IPO. The SPAC is targeting sectors with scalable business models, particularly in healthcare and technology, aiming to leverage its sponsor’s expertise in strategic growth and operational improvement.

SPAC IPO: West Enclave Merger Corp. (WENC)
Ticker: WENC
Size: $100 Million
Sponsor: West Enclave Partners

West Enclave Merger Corp. has initiated its $100 million IPO, focusing on sustainable and innovative business practices. The SPAC aims to identify targets in renewable energy and technology, sectors poised for significant growth and transformation.

New SPAC IPOs
Date Ticker Issuer IPO Size
Apr 30 ARBC ARC Group Acquisition I Corp. $105M
Apr 30 FTHA Forefront Tech Holdings Acquisition Corp $100M
Apr 30 GCGR General Catalyst Global Resilience Merger Corp. $350M
Apr 30 MCAH Mountain Crest Acquisition 6 Corp. $60M
Apr 30 RREV RRE Ventures Acquisition Corp. $250M
Apr 30 WENC West Enclave Merger Corp. $100M
Apr 29 CAII Collective Acquisition Corp. II $220M
Apr 28 CXII CHURCHILL CAPITAL CORP XII $360M  $54M overallotment
Apr 28 IACQ IRENIC ACQUISITION CORP $220M
Apr 28 PLUN PLUTONIAN ACQUISITION CORP II $100M
Source: Boardroom Alpha

Daily SPAC Update

SVAC – SPRING VALLEY ACQUISITION CORP III * Investor Deck
BCAR – D BORAL ARC ACQUISITION I CORP * Investor Deck
ATII – ARCHIMEDES TECH SPAC PARTNERS II CO * Media Transcript
CEPO – CANTOR EQUITY PARTNERS I INC * Podcast Transcript
GPAT – GP-ACT III ACQUISITION CORP * Vote Adjourned

SPAC DEALS ANNOUNCED
Apr 27 | MMTX – Miluna Acquisition Corp + CADV Ventures S.A.

ABOUT CADV Ventures S.A.

CADV.AI is an AI software company founded in 2017 and headquartered in Warsaw, Poland, focused on improving digital customer engagement for large organizations. CADV.AI’s mission is to deliver mission-critical solutions with uncompromising quality and reliability, enabling its customers to succeed in the most demanding environments. CADV.AI provides advanced technical support for organizations using extensive IT systems and delivers technical support services using an AI-assisted support model in which the CADV.AI platform analyzes incidents and automates operational tasks while expert engineers supervise the process and resolve complex cases. As a result, its clients benefit from a modern technical support model that combines the expertise of IT professionals with the capabilities of artificial intelligence. CADV.AI offers an IT protection service package that includes technical support for IT systems. This solution provides organizations with guaranteed access to a team of IT specialists in situations requiring a response to technical incidents or operational issues.

SPAC Movers

YESTERDAY’S TOP SPAC GAINERS
Company Ticker Change Price Stage
RISING DRAGON ACQUISITION CORP RDAC 318.6% $ 20.51 Announced
HORIZON SPACE ACQUISITION II CORP HSPT 26.7% $ 10.01 Announced
BLUEPORT ACQUISITION LTD BPAC 14.3% $ 11.49 Pre-Deal
ASPAC III ACQUISITION CORP ASPC 8.7% $ 12.00 Announced
WILLOW LANE ACQUISITION CORP WLAC 3.9% $ 16.99 Announced
YESTERDAY’S TOP SPAC LOSERS
Company Ticker Change Price Stage
GENERAL PURPOSE ACQUISITION CORP GPAC -21.7% $ 9.97 Pre-Deal
VOYAGER ACQUISITION CORP VACH -4.6% $ 12.25 Announced
JATT II ACQUISITION CORP TBD -2.5% $ 10.65 Pre-Deal
APARADISE ACQUISITION CORP APAD -1.8% $ 10.05 Announced
LEGATO MERGER CORP III LEGT -0.9% $ 11.05 Announced
Source: Boardroom Alpha market data

Recent Analysis

Daily SPAC Update – April 29, 2026

Collective Acquisition Corp. II (CAII) launched its $220 million IPO today, targeting high-potential sectors like technology and healthcare. In executive moves, Roger Bendelac was appointed CEO of both Drugs Made in America Acquisition Corp (DMAA) and Drugs Made in America Acquisition II Corp (DMII), with Saleem Elmasri as CFO. Meanwhile, General Purpose Acquisition Corp (GPAC) saw a significant decline of 22.9%, closing at $9.96, while Aimei Health Technology Co Ltd (AFJK) gained 2.7% to $46.12.

Daily SPAC Update – April 28, 2026

SPAC IPOs Look Stalled Again as Irenic’s $220M IPO Only Makes it Seven. Miluna Acquisition + CADV.AI Deal. Prophyte Extension Vote to Add 12 More Months.

Daily SPAC Update – April 20, 2026

Piermont Announces Deal with Tigerless Health. Climaterock sets extension vote. Horizon Space Extension Vote Today. Suma, TRG Latin America, and MOZAYYX Separate Trading.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.